Skip to content

Access Troponin I Reagents on the Access Immunoassay Analyzer

by Beckman Instruments, Inc.

510(k) K974075

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK974075 Date10 Nov 1997ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MMI
Device Class
Class II
Regulation
21 CFR Part 862.1215
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Access Troponin I Reagents are an immunoassay method designed for the quantitative measurement of cardiac troponin I (cTnI) in human serum or plasma. This device employs a paramagnetic-particle, chemiluminescent sandwich immunoassay principle to detect and quantify troponin I levels, a biomarker used in the diagnosis and monitoring of acute myocardial infarction and other cardiac conditions.

These reagents are intended for use exclusively on the Access Immunoassay Analyzer, a clinical chemistry instrument. Supplied as a single-use reagent kit, the device requires no special storage conditions beyond those specified in the instructions for use. The reagents are classified under FDA 510(k) clearance (K974075) and fall under the regulatory category of medical device class 2 (862.1215). No additional regulatory status is implied beyond what is explicitly stated.

Other devices from Beckman Instruments, Inc.

See all devices from Beckman Instruments, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical conditions is this reagent kit designed to help diagnose or monitor?

    The Access Troponin I Reagents are specifically designed for the quantitative measurement of cardiac troponin I (cTnI) in human serum or plasma. Troponin I is a biomarker used primarily in the diagnosis and monitoring of acute myocardial infarction (heart attack) and other cardiac conditions, helping clinicians assess heart damage or risk.

  • Is this reagent kit single-use, or can it be reused across multiple tests?

    The Access Troponin I Reagents are supplied as a single-use reagent kit. This means each kit is intended for one use only and should not be reused, ensuring accuracy and maintaining sterility for reliable test results.

  • What storage requirements does this reagent kit have beyond standard laboratory conditions?

    According to the provided data, the reagents require no special storage conditions beyond those specified in the instructions for use. This means they can be stored under typical clinical laboratory conditions, but always follow the manufacturer’s guidelines for optimal performance.

  • Which clinical chemistry analyzer is required to use these reagents?

    The Access Troponin I Reagents are designed exclusively for use on the Access Immunoassay Analyzer, a dedicated clinical chemistry instrument. They are not compatible with other analyzers, so this analyzer must be available for testing.

  • What regulatory pathway was followed for FDA clearance of this device?

    The Access Troponin I Reagents received FDA clearance through a 510(k) premarket notification process, specifically under the Traditional Review pathway. The device was determined to be substantially equivalent to a predicate product and falls under FDA classification 2 (862.1215), with the Clinical Chemistry (CH) Advisory Committee involved in the review.